C.q. Pharmaceutical Holding (000950.SZ) announced its third-quarter report on October 24th. In the third quarter of 2024, the company achieved a revenue of 19.913 billion yuan, an increase of 12.70% year-on-year; the net income attributable to shareholders of the listed company was 54.137 million yuan, an increase of 1,269.44% year-on-year; the net income after deducting non-recurring gains and losses was 58.7922 million yuan, an increase of 1,342.83% year-on-year; and the basic earnings per share was 0.03 yuan/share.
重药控股(000950.SZ)：第三季度净利润5413.70万元，同比增长1269.44%
c.q. pharmaceutical holding (000950.SZ): net income in the third quarter was 54.137 million yuan, a year-on-year increase of 1269.44%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha